﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 16 Apr 2026 15:43:03 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/June-2021/rss/1698</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/June-2021/rss/1698" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-11</link><description><![CDATA[  New drugs  

 DASIGLUCAGON INJECTION 
(Zegalogue—Zealand Pharma) 

  Drug class:  Antihypoglycemic. 

  Indication:  Autoinjector and prefilled syringe for S.C. injection to treat severe ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-11</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2090]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[‘Long COVID’ needs to be addressed by multiple specialties]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/long-covid-needs-to-be-addressed-by-multiple-specialties</link><description><![CDATA[  Loren Bonner  

   

 More and more cases of “long COVID” are surfacing—but what does it mean, and how can clinicians respond? Patients who present with long COVID—also called long-haul COVID ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/long-covid-needs-to-be-addressed-by-multiple-specialties</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2083]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[What you need to know about SARS-CoV-2 variants]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-you-need-to-know-about-sars-cov-2-variants</link><description><![CDATA[  Loren Bonner  

   

 Why were SARS-CoV-2 variants expected? 

 “Ultimately, all viruses mutate all the time,” said Scott Roberts, MD, from Yale New Haven Health. 

 Labs have been tracking ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-you-need-to-know-about-sars-cov-2-variants</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2084]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Is melatonin safe for children?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/is-melatonin-safe-for-children</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 Since melatonin is naturally produced in the body and adults commonly use melatonin to fall asleep, what’s the harm in giving children melatonin to sleep? ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/is-melatonin-safe-for-children</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2085]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Cannabis could help manage symptoms of some neurological conditions]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/cannabis-could-help-manage-symptoms-of-some-neurological-conditions</link><description><![CDATA[  Loren Bonner  

   

 The data on cannabis and its components for treatment of neurological disorders are plentiful, according to Michele Faulkner, PharmD, FASHP. “Cannabis and neurological ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/cannabis-could-help-manage-symptoms-of-some-neurological-conditions</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2086]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Warts: A benign but contagious condition]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/warts-a-benign-but-contagious-condition</link><description><![CDATA[  Daniel L. Krinsky, RPh, MS  

   

 Warts, a common skin disorder caused by the human papillomavirus (HPV), are considered a benign condition that often resolves without treatment. Warts may ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/warts-a-benign-but-contagious-condition</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2087]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Ashwagandha for reduced stress and anxiety]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/ashwagandha-for-reduced-stress-and-anxiety</link><description><![CDATA[  Mickie Cathers  

   

  Ashwagandha (Withania somnifera  ),  a small perennial shrub with yellow flowers, is a key component of Ayurveda, the traditional practice of medicine developed more ...]]></description><pubDate>Mon, 07 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/ashwagandha-for-reduced-stress-and-anxiety</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2088]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Dual-action ADHD drug provides both early- and late-onset symptom relief]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dual-action-adhd-drug-provides-both-early-and-late-onset-symptom-relief</link><description><![CDATA[  Cara Aldridge Young  

 FDA has approved Azstarys (KemPharm), the first ADHD medication to combine two medications, 70% serdexmethylphenidate (SDX) and 30% immediate-release dexmethylphenidate ...]]></description><pubDate>Tue, 22 Jun 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dual-action-adhd-drug-provides-both-early-and-late-onset-symptom-relief</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2089]]></dc:identifier></item></channel></rss>